Key facts
- VitalConnect’s last known valuation is $463.0M (Feb 2025).
- It has raised $382.9M; the latest was Later Stage VC ($100.0M) in Feb 2025.
- Notable investors include Revelation Partners, Ally Bridge Group, EW Healthcare Partners, Asahi Kasei Corporate Venture Capital, Baxter Ventures — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for VitalConnect
- ·The full record, as it builds
Funding rounds
No funding rounds for VitalConnect are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About VitalConnect
Developer of wearable biosensor technology designed to continuously monitor and record patients' vital signs. The company's technology uses an adhesive patch to stick to the body and leverages biomedical engineering, data analytics, and chip design which can be displayed on mobile devices or computer systems, enabling healthcare professionals to respond immediately to urgent situations and access unprecedented insight into patient health to aid in critical decisions.
- Sector
- Healthcare
- HQ
- San Jose, CA, United States
- Founded
- 2011
- Employees
- 183
- Website
- vitalconnect.com/
- Ownership
- Privately Held (backing)
VitalConnect doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in VitalConnect shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on VitalConnect in its N-PORT filings yet. We sweep new filings monthly.